Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1076 | 1002 | 1221 | 1025 | 1626 | 2309 |
Fund Return | 7.57% | 0.16% | 22.12% | 0.82% | 10.21% | 8.73% |
Place in category | 300 | 224 | 71 | 257 | 64 | 68 |
% in Category | 64 | 52 | 11 | 70 | 14 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AllianzIncome Growth IT H2EUR | 49.34B | 7.48 | 0.41 | 5.48 | ||
AllianzIncome Growth CT H2EUR | 49.34B | 6.28 | -1.06 | 3.93 | ||
AllianzIncome Growth RT H2EUR | 49.34B | 7.36 | 0.24 | - | ||
AllianzIncome Growth AT H2EUR | 49.34B | 6.87 | -0.29 | 4.73 | ||
Allianz Income and Growth P EUR | 49.34B | 7.28 | 3.73 | 8.68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth A EUR | 3.29B | 7.64 | -0.75 | 7.77 | ||
Allianz Europe Equity Growth AT EUR | 3.29B | 7.64 | -0.75 | 7.77 | ||
Allianz Europe Equity Growth P EUR | 3.29B | 8.34 | 0.10 | 8.69 | ||
Allianz Europe Equity Growth I EUR | 3.29B | 8.37 | 0.14 | 8.74 | ||
Allianz Europe Equity Growth PT EUR | 3.29B | 8.34 | 0.10 | 8.69 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 8.17 | 627.10 | +0.95% | |
Novo Nordisk B | DK0062498333 | 7.75 | 768.9 | +0.76% | |
DSV | DK0060079531 | 5.26 | 1,519.0 | +1.91% | |
SAP | DE0007164600 | 4.93 | 216.750 | +0.91% | |
Sika | CH0418792922 | 4.68 | 242.90 | +1.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review